Jeffery Carter

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 324 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Favorable Human Half-life +11

The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate

Jane L. Wang, Jeffery Carter, James R. Kiefer et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Biochemistry +12

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates

Jane L. Wang, Karl Aston, David C. Limburg et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 36 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Pharmaceutical Chemistry +12

Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors

James K. Gierse, Maureen A. Nickols, K. Leahy et al. · European Journal of Pharmacology · 2008 · 34 citations

Cox-1/cox-2 Selectivity, Medicinal Chemistry, Oncology +8

Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors

Xing Li, Bruce C. Hamper, Theresa Fletcher et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 12 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Bioorganic Chemistry +11